Oil prices surged Tuesday as hopes for a U.S.-Iran war resolution dimmed, keeping the vital Strait of Hormuz largely closed and impacting global energy supplies. Analysts predict continued price hikes, with some forecasting Brent crude could reach $150 per barrel if disruptions persist, underscoring significant economic risks.Read More
Six Nifty 500 stocks, including Sun Pharma and Shyam Metalics, showed a bullish RSI upswing on April 27 after gaining over 6%. The move above the 50 RSI level signals strengthening momentum, often tracked by traders to identify potential buying opportunities in stocks showing upward price trends.Read More
Sun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It also offers diversification into new segments like women’s health and biosimilars. The acquisition is expected to strengthen Sun Pharma’s position for future growth. Managing integration and debt will be key.Read More
Indian stock markets ended a three-day losing streak with a gain of 0.8 percent on Monday. This rise followed positive movements in Asian markets. Investors showed buying interest in heavyweights like Reliance Industries and Sun Pharmaceuticals. All sectoral indices closed higher. The India VIX volatility index saw a decrease. Foreign portfolio investors sold shares, while...Read More
Axis Bank shares fell 3% despite analysts maintaining a positive outlook, with 94% recommending ‘Buy’. The bank’s loan growth was strong, but provisions for the West Asia conflict rose significantly, impacting performance. Management’s cautious approach to strengthening provisions, while improving asset quality, led to higher credit costs.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
